| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/2005 | EP1495052A1 Modified factor viii |
| 01/12/2005 | EP1495051A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 01/12/2005 | EP1495050A1 Novel antagonists of mcp proteins |
| 01/12/2005 | EP1495049A2 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| 01/12/2005 | EP1495048A2 Heterogenenous protein networks crosslinked with silicone-containing links,and methos for producing them |
| 01/12/2005 | EP1495047A2 Synthetic active peptide fragments |
| 01/12/2005 | EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists |
| 01/12/2005 | EP1495039A2 Neisseria mutants, lipooligosaccharides and immunogenic compositions |
| 01/12/2005 | EP1494728A2 Tissue defect dressings comprising a keratin network |
| 01/12/2005 | EP1494722A1 Treatment methods for eotaxin mediated inflammatory conditions |
| 01/12/2005 | EP1494713A2 Methods for treating tweak-related conditions |
| 01/12/2005 | EP1494708A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 01/12/2005 | EP1494707A2 Synthetic peptides and dna sequences for treatment of multiple sclerosis |
| 01/12/2005 | EP1494704A1 Glp-1 agonist and cardiovascular complications |
| 01/12/2005 | EP1494703A1 Chemokines mutants having improved oral bioavailability |
| 01/12/2005 | EP1494697A1 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/12/2005 | EP1494694A2 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging |
| 01/12/2005 | EP1494693A2 Cripto-specific antibodies |
| 01/12/2005 | EP1494613A2 Potent oncolytic herpes simplex virus for cancer therapy |
| 01/12/2005 | EP1494541A1 Canola protein isolate compositions |
| 01/12/2005 | EP1494536A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 01/12/2005 | EP1443970A4 Promoters exhibiting endothelial cell specificity and methods of using same |
| 01/12/2005 | EP1373499A4 Hin-1, a tumor suppressor gene |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP1299724A4 Synthetic peptide for neurological disorders |
| 01/12/2005 | EP1268512B1 A computer based method for identifying conserved invariant peptide motifs |
| 01/12/2005 | EP1242157B1 Methods for preparing blood or plasma component solutions with improved concentrations |
| 01/12/2005 | EP1233023B1 Transcription factor and dna thereof |
| 01/12/2005 | EP1117686A4 Methods and materials for detection and measurement of free radical damage |
| 01/12/2005 | EP1002082B1 Transcriptional silencer protein nrf |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0861021A4 Modified bacillus thuringiensis gene for lepidopteran control in plants |
| 01/12/2005 | EP0848753B1 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 01/12/2005 | EP0770088B1 Novel cytokine designated lerk-5 |
| 01/12/2005 | EP0750513B1 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 01/12/2005 | EP0710251B1 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 01/12/2005 | EP0627923B1 Therapeutic domains of von willebrand factor |
| 01/12/2005 | EP0568575B1 Test and model for alzheimer's disease |
| 01/12/2005 | EP0318554B2 Targeted multifunctional proteins |
| 01/12/2005 | CN1564870A Plant transcriptional repressor, proteic nuclear factors binding thereto, and uses thereof |
| 01/12/2005 | CN1564868A Enzyme gene participating in the synthesis of polyester and process for producing polyester using the same |
| 01/12/2005 | CN1564867A DNA-expression construct for treatment of infections with leishmaniasis |
| 01/12/2005 | CN1564863A Method for production of recombinant proteins in eukaryote cells |
| 01/12/2005 | CN1564829A Antibodies to insulin-like growth factor I receptor |
| 01/12/2005 | CN1564828A Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/12/2005 | CN1564827A Polypeptide purification method |
| 01/12/2005 | CN1564826A Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 01/12/2005 | CN1564694A Method for improving immune response |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1563406A Purification technique in preparing genetic engineering vaccine of heat shock protein A of recombined Helicobacter pylori |
| 01/12/2005 | CN1563382A Gene of Chinese Mainland SJPP gene stock of japanese blood fluke, clone, expression and application |
| 01/12/2005 | CN1563381A Deactivated protein gene in ribosome of motherwort |
| 01/12/2005 | CN1563380A Gene oder of directivity and differentiation factor 1 fat cell of pigs |
| 01/12/2005 | CN1563087A Polypeptide of ramification of ciliary nerves nutrilite for curing obesity |
| 01/12/2005 | CN1563086A Technique for preparing bioactive peptide of bursa of Fabricius |
| 01/12/2005 | CN1563085A Recombined silk protein from major ampullate of Argiope amoena L.Koch and preparation method |
| 01/12/2005 | CN1563084A 0sGLR1 gene of paddy and application |
| 01/12/2005 | CN1563083A Method for preparing phycocyanin from blue algae in water bloom |
| 01/12/2005 | CN1563082A Method for purifying microcysin |
| 01/12/2005 | CN1563081A Method for separating and purifying toxin of microcapsule alga |
| 01/12/2005 | CN1563024A Method for extracting toxin of synnema alga |
| 01/12/2005 | CN1184319C Chemosynthesized SARS virus S gene segement, its expression and application |
| 01/12/2005 | CN1184318C Actinine fluorescent protein novel gene and its cloning, expression and use |
| 01/12/2005 | CN1184317C Modifying method and application of exilis protein gene |
| 01/12/2005 | CN1184315C Death domain containing receptor 5 |
| 01/12/2005 | CN1184313C Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
| 01/12/2005 | CN1184235C Chimeric polypeptides, method for production and uses thereof |
| 01/12/2005 | CN1184234C Preparation of stable zinc insulin analog crystals |
| 01/12/2005 | CN1184233C Erytrocyte-stimulating factor coupling |
| 01/12/2005 | CN1184232C Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition |
| 01/12/2005 | CN1184231C Wheat TaDREB, its code gene and method for culturing adverse-resistant plant |
| 01/12/2005 | CN1183961C Remedies for bone metabolic errors |
| 01/11/2005 | US6841722 Comprises nucleotide sequences coding shrunken (SSEI) protein for generating plant with improved storage and oil body biogenesis |
| 01/11/2005 | US6841720 Inducible promoters |
| 01/11/2005 | US6841659 Method for recovering proteins from the interstitial fluid of plant tissues |
| 01/11/2005 | US6841658 Isolating preferential polypeptide; obtain sample, incubate with ion exchange resin, elute, recover polypeptide |
| 01/11/2005 | US6841657 Inhibitors of HIV membrane fusion |
| 01/11/2005 | US6841579 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/11/2005 | US6841535 Peptide-mediated transfection agents and methods of use |
| 01/11/2005 | US6841534 For inhibiting blood coagulation |
| 01/11/2005 | US6841533 Overcoming the drawbacks of the native peptide molecules (low metabolic stability, poor oral bio-availability, rapid liver and kidney excretion, and lack of selectivity), thereby providing improved therapeutic properties |
| 01/11/2005 | US6841532 Peptides and their use to ameliorate cell death |
| 01/11/2005 | US6841531 For promoting the survival, growth, proliferation, or maintenance of mammalian neurons; accelerating wound healing while minimizing or inhibiting scar formation and keloid formation |
| 01/11/2005 | US6841385 Transcription factor E2F DNA-binding domain inhibitor peptides and their use |
| 01/11/2005 | US6841383 Insertion of preferential nucleotide seqences into genome; ontain nucleotide sequences, incubate with cells, transform recover cell expressing preferential marker |
| 01/11/2005 | US6841382 Nucleotide sequences coding protein for use in treatment of cancer, inflammation, arthritis and psoriasis |
| 01/11/2005 | US6841381 Immunization by inoculation of DNA transcription unit |
| 01/11/2005 | US6841373 Preparing replication defective viral vector for gene transfer tool; genetic engineering |
| 01/11/2005 | US6841367 Human receptor tyrosine kinase, KDR |
| 01/11/2005 | US6841366 Biotin biosynthesis in bacillus subtilis |
| 01/11/2005 | US6841364 Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof |
| 01/11/2005 | US6841363 Preparation of capped mRNA |
| 01/11/2005 | US6841361 Methods of producing recombinant insulin from novel fused proteins |
| 01/11/2005 | US6841360 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 01/11/2005 | US6841359 Peptide for use as diagnostic tool in protein analysis |
| 01/11/2005 | US6841358 Recombinant proteins of filamentous haemagglutinin of bordetella, particularly bordetella pertussis, method for producing same, and uses thereof for producing foreign proteins of vaccinating active principles |
| 01/11/2005 | US6841355 Positioning solid support into injury; wound healing agents; peptide |
| 01/11/2005 | US6841353 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 01/11/2005 | US6841348 Methods for identifying and using maintenance genes |
| 01/11/2005 | US6841165 Insecticidal agents |